deoxyglucose has been researched along with Lymphoma, Primary Effusion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Accordi, B; Baracca, A; Basso, G; Bertacchini, J; Bonora, M; Bosco, R; Calabrò, ML; Capitani, S; Cocco, L; De Pol, A; Frasson, C; Gibellini, F; Luppi, M; Marmiroli, S; Mattiolo, A; Mediani, L; Milani, D; Petrizza, L; Pinton, P; Potenza, L; Prodi, L; Rampazzo, E; Riva, G; Sgarbi, G | 1 |
1 other study(ies) available for deoxyglucose and Lymphoma, Primary Effusion
| Article | Year |
|---|---|
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.
Topics: Apoptosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Coculture Techniques; Deoxyglucose; Epithelium; Flow Cytometry; Glycolysis; Humans; Lymphoma, Primary Effusion; Phenotype; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Array Analysis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridones; Pyrimidines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |